Skip to main content
. 2023 Sep 27;15(19):4754. doi: 10.3390/cancers15194754

Figure 1.

Figure 1

Upper row left: LN with capsular fibrosis (≤30%, H&E, 50×); middle: LN with low framework fibrosis and moderate lipomatous atrophy (31–60%, H&E, 25×); right: LN with subtotal lipomatous atrophy (≥61%, H&E, 25×). Lower row left: LN with low framework fibrosis, capsular fibrosis and subtotal lipomatous atrophy (≥61%, H&E, 50×); right: LN with moderate framework fibrosis and calcifications (H&E, 100×).